Zinc acetate lozenges may shorten common cold duration by up to 40%

[eLetter]

Tutkimustuotos: ArtikkelijulkaisuKommenttiTieteellinen

Kuvaus

The systematic review by Dr. Science et al. has a number of problems. ...
Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).
Alkuperäiskielienglanti
LehtiCMAJ
Vuosikerta184
Numero10
ISSN0820-3946
TilaJulkaistu - 2012
OKM-julkaisutyyppiB1 Kirjoitus tieteellisessä aikakauslehdessä

Lisätietoja

Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40%
Volume:
Proceeding volume:

Tieteenalat

  • 3125 Korva-, nenä- ja kurkkutaudit, silmätaudit
  • 317 Farmasia

Lainaa tätä

@article{1c1d6c501eb348d3ba5a78ace4405429,
title = "Zinc acetate lozenges may shorten common cold duration by up to 40{\%}: [eLetter]",
abstract = "The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).",
keywords = "3125 Otorhinolaryngology, ophthalmology, 317 Pharmacy, upper respiratory infections, zinc lozenges, RANDOMIZED TRIALS, Systematic review",
author = "Harri Hemil{\"a}",
note = "Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40{\%} Volume: Proceeding volume:",
year = "2012",
language = "English",
volume = "184",
journal = "CMAJ",
issn = "0820-3946",
publisher = "CANADIAN MEDICAL ASSOCIATION",
number = "10",

}

Zinc acetate lozenges may shorten common cold duration by up to 40% : [eLetter]. / Hemilä, Harri.

julkaisussa: CMAJ, Vuosikerta 184, Nro 10, 2012.

Tutkimustuotos: ArtikkelijulkaisuKommenttiTieteellinen

TY - JOUR

T1 - Zinc acetate lozenges may shorten common cold duration by up to 40%

T2 - [eLetter]

AU - Hemilä, Harri

N1 - Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40% Volume: Proceeding volume:

PY - 2012

Y1 - 2012

N2 - The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).

AB - The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).

KW - 3125 Otorhinolaryngology, ophthalmology

KW - 317 Pharmacy

KW - upper respiratory infections

KW - zinc lozenges

KW - RANDOMIZED TRIALS

KW - Systematic review

M3 - Comment/debate

VL - 184

JO - CMAJ

JF - CMAJ

SN - 0820-3946

IS - 10

ER -